End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.5 CNY | +5.31% | +6.32% | +5.54% |
May. 24 | Mabwell Announces 9MW2821 Clinical Data | CI |
May. 13 | Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Equities
- 688062 Stock
- Revisions Mabwell (Shanghai) Bioscience Co., Ltd.